Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients

International guidelines consider quetiapine at medium doses (300–400 mg/day) as valid options for the treatment of bipolar depression for the supposed lower risk of a switch to hypomania/mania than antidepressants. Norquetiapine is an active metabolite with antidepressant action. We describe three...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Saf Case Rep
Prif Awduron: Rovera, C., Esposito, C. M., Ciappolino, V., Cattaneo, D., Baldelli, S., Clementi, E., Altamura, A. C., Buoli, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer International Publishing 2017
Pynciau:
Case Series
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5653679/
https://ncbi.nlm.nih.gov/pubmed/29063217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40800-017-0057-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg